Cargando…
Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer
Tumor-specific targeting with fluorescent probes can enhance contrast for identification of cancer during surgical resection and visualize otherwise invisible tumor margins. Nanobodies are the smallest naturally-occurring antigen-binding molecules with rapid pharmacokinetics. The present work demons...
Autores principales: | Lwin, Thinzar M., Turner, Michael A., Nishino, Hiroto, Amirfakhri, Siamak, Hernot, Sophie, Hoffman, Robert M., Bouvet, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138244/ https://www.ncbi.nlm.nih.gov/pubmed/35625638 http://dx.doi.org/10.3390/biom12050711 |
Ejemplares similares
-
The Use of Fluorescent Anti-CEA Antibodies to Label, Resect and Treat Cancers: A Review
por: Turner, Michael A., et al.
Publicado: (2021) -
Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible
por: Lwin, Thinzar M., et al.
Publicado: (2022) -
Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreatic Cancer Therapy in an Orthotopic Mouse Model
por: Nishino, Hiroto, et al.
Publicado: (2022) -
Unique Benefits of Tumor-Specific Nanobodies for Fluorescence Guided Surgery
por: Lwin, Thinzar M., et al.
Publicado: (2021) -
Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model
por: Lwin, Thinzar M., et al.
Publicado: (2018)